1. Bartik MM, Baumgartel-Scofield BA, Mokyr MB (1991) Enhanced expansion of the thymic CD8+ cell subsets as a potential mechanism for the generation of enhanced antitumor cytotoxicity by thymocytes from low-dose melphalan-treated MOPC-315 tumor bearers. Cancer Immunol Immunother 34:79
2. Cowens JW, Ozer H, Ehrke MJ, Greco WR, Colvin M, Mihich E (1984) Inhibition of the development of suppressor cells in culture by 4-hydroperoxycyclophosphamide. J Immunol 132:95
3. DeVita V Jr (1990) The problem of resistance; keynote address. In: Mihich E (ed) Drug resistance: mechanisms and reversal. Libbey, New York, p 7
4. Dray S, Mokyr MB (1989) Cyclophosphamide and melphalan as immunopotentiating agents in cancer therapy. Med Oncol Tumor Pharmacother 6:7
5. Ehrke MJ, Mihich E (1985) Immunoregulation by cancer chemotherapeutic agents. In: Hadden JW, Szentivanyi A (eds) The reticuloendothelial system: a comprehensive treatise, vol 8. Pharmacology. Pergamon, New York, p 309